RemeGen Co., Ltd.

HKEX:9995.HK

11.66 (HKD) • At close September 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q22018 Q12017 Q4
Revenue 330.435313.483350.397254.189168.239198.139220.857200.24150.1351,309.39585.31524.914.2820000000002.832.832.83
Cost of Revenue 74.3679.47575.14478.94625.10746.36856.06670.62997.50956.9075.6163.3711.2690000000002.2332.2332.233
Gross Profit 256.075234.008275.253175.242143.132151.772164.79129.61152.6261,252.48879.69921.5393.0130000000000.5970.5970.597
Gross Profit Ratio 0.7750.7460.7860.6890.8510.7660.7460.6470.3510.9570.9340.8650.7040000000000.2110.2110.211
Reseach & Development Expenses 331.179448.329317.525290.731249.722319.539212.869231.498218.174186.348198.021190.489136.115138.79138.79113.03275.2196.05796.05790.81569.13788.01754.1154.1154.11
General & Administrative Expenses 74.2661.36174.25785.17978.745111.88453.73954.90149.05660.55360.66749.87848.74279.47679.47638.33620.33622.5922.5914.8348.428.1952.3432.3432.343
Selling & Marketing Expenses 187.505235.395189.623192.349157.819163.041127.69469.17780.784134.23167.84439.15321.7399.8389.8383.1981.3060.3110.3110.1550.1550.155000
SG&A 266.424298.423263.88279.716234.673274.925181.433127.683131.305194.429128.91388.06671.5289.07789.07741.63722.0622.44522.44515.438.7368.35-53.73-53.73-53.73
Other Expenses 00-21.36700-28.856-28.83000000000000-96.142-96.142-96.142000
Operating Expenses 595.556719.808587.283557.676474.304446.51398.853351.976348.552296.315339.699284.011198.481218.017218.017143.6490.862105.894105.89499.51675.3340.2250.380.380.38
Operating Income -334.91-488.935-315.441-396.755-332.042-305.81-205.9-226.683-291.015814.335-224.507-270.711-197.511-228.985-228.985-155.632-97.854-120.076-120.076-106.732-77.882-96.623-57.473-57.473-57.473
Operating Income Ratio -1.014-1.56-0.9-1.561-1.974-1.543-0.932-1.132-1.9380.622-2.632-10.867-46.131000000000-20.307-20.307-20.307
Total Other Income Expenses Net -14.0128.292-11.78317.1698.268-4.86.80624.3884.185150.183-19.7111.15113.0284.9924.9925.39-1.7395.8245.824-7.282-9.879-10.947-10.014-10.014-10.014
Income Before Tax -348.922-480.643-327.224-379.586-323.775-310.611-199.093-202.295-286.831964.517-244.216-259.56-184.483-223.993-223.993-150.242-99.593-114.253-114.253-114.014-87.761-107.57-67.487-67.487-67.487
Income Before Tax Ratio -1.056-1.533-0.934-1.493-1.924-1.568-0.901-1.01-1.910.737-2.863-10.42-43.088000000000-23.845-23.845-23.845
Income Tax Expense 42.9610-30.35900-30.359-16.55900000000000010.94710.94710.94710.01410.01410.014
Net Income -348.922-480.643-327.224-379.586-323.775-310.611-199.093-202.295-286.831964.517-244.216-259.56-184.483-223.993-223.993-150.242-99.593-114.253-114.253-114.014-87.761-118.517-77.501-77.501-77.501
Net Income Ratio -1.056-1.533-0.934-1.493-1.924-1.568-0.901-1.01-1.910.737-2.863-10.42-43.088000000000-27.383-27.383-27.383
EPS -0.65-0.89-0.61-0.7-0.6-0.58-0.37-0.38-0.591.99-0.5-0.53-0.38-0.46-0.46-0.37-0.55-0.24-0.24-0.24-0.18-0.25-0.16-0.16-0.16
EPS Diluted -0.65-0.89-0.61-0.7-0.6-0.56-0.37-0.38-0.591.99-0.5-0.53-0.38-0.46-0.46-0.37-0.55-0.24-0.24-0.24-0.18-0.25-0.16-0.16-0.16
EBITDA -291.906-445.931-315.441-357.379-301.034-305.81-205.9-197.462-274.456830.894-212.033-255.393-185.038-215.967-215.967-143.572-86.056-109.235-109.235-96.777-68.517-85.93-51.814-51.814-51.814
EBITDA Ratio -0.883-1.423-0.9-1.406-1.789-1.543-0.932-0.986-1.8280.635-2.485-10.252-43.217000000000-18.307-18.307-18.307